By Elric Langton | 28 April 2022
I have a financial interest in Poolbeg Pharma
Poolbeg PharmaΒ (AIM: POLB, OTCQB: POLBF), a clinical-stage infectious disease pharmaceutical company with a unique capital-light clinical model, announces the results of the proposal from several New Investors to purchase shares from distribution in-specie shareholders ahead ofβ¦